BamSEC and AlphaSense Join Forces
Learn More

Anika Therapeutics Inc.

NASDAQ: ANIK    
Share price (8/22/25): $9.65    
Market cap (8/22/25): $139 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 20 pages Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan
12/34/56
EX-10.1B
from 10-Q 15 pages Notice of Grant of Performance Restricted Stock Units Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan
12/34/56
EX-10.1A
from 10-Q 14 pages Notice of Grant of Performance Restricted Stock Units Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan
12/34/56
EX-10.15
from 10-K 9 pages Anika Therapeutics, Inc. Executive Retention Agreement
12/34/56
EX-10.13
from 10-K 9 pages Anika Therapeutics, Inc. Executive Retention Agreement
12/34/56
EX-10.10L
from 10-K 12 pages Notice of Grant of Restricted Stock Units Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 23 pages Cooperation Agreement
12/34/56
EX-10.4
from 8-K 9 pages May 2, 2024 Michael Levitz Re: Transitional Services and Separation Agreement 1. Separation Date; Transition Period
12/34/56
EX-10.2
from 8-K 9 pages Anika Therapeutics, Inc. Executive Retention Agreement
12/34/56
EX-10.1
from 8-K 5 pages Material contract
12/34/56
EX-10.10B
from 10-K/A 13 pages Notice of Grant of Restricted Stock Units Anika Therapeutics, Inc. 2021 Inducement Plan
12/34/56
EX-10.10A
from 10-K/A 13 pages Notice of Grant of Restricted Stock Units Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan
12/34/56
EX-10.14
from 10-K 10 pages Anika Therapeutics, Inc. Executive Retention Agreement
12/34/56
EX-10.8
from 10-K 2 pages Anika Therapeutics, Inc. Restated Director Compensation Policy
12/34/56
EX-10.1
from 8-K 20 pages Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan
12/34/56
EX-10.1
from 8-K 18 pages Cooperation Agreement
12/34/56
EX-10.13
from 10-K 9 pages Anika Therapeutics, Inc. Executive Retention Agreement
12/34/56
EX-10.1
from 8-K 20 pages Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan
12/34/56
EX-10.12
from 10-K 10 pages Material contract
12/34/56
EX-10.10K
from 10-K 13 pages Notice of Grant of Deferred Stock Units Anika Therapeutics, Inc. 2021 Inducement Plan
12/34/56